Morpholino

MO2-tnfrsf1a

ID

ZDB-MRPHLNO-080326-2

Name

MO2-tnfrsf1a

Previous Names

Target

Sequence

5' - CTGCATTGTGACTTACTTATCGCAC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

splice blocker

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-tnfrsf1a

Expressed Gene	Anatomy	Figures
baxa	whole organism	Fig. 4 from Espín et al., 2013
casp8	whole organism	Fig. 4 from Espín et al., 2013
mdm2	whole organism	Fig. 4 from Espín et al., 2013
myb	ventral wall of dorsal aorta hematopoietic stem cell	Fig. 1 from Espín-Palazón et al., 2014
tp53	whole organism	Fig. 4 from Espín et al., 2013

Phenotype

Phenotype resulting from MO2-tnfrsf1a

No data available

Phenotype of all Fish created by or utilizing MO2-tnfrsf1a

Phenotype	Fish	Conditions	Figures
whole organism decreased life span, exacerbated	AB + MO2-tnfrsf1a	viral treatment by exposure to environment: Sprivivirus cyprinus	Fig. 2 from Espín-Palazón et al., 2016
granuloma formation accelerated growth, abnormal	WIK + MO1-tnfrsf1a + MO2-tnfrsf1a	bacterial treatment: Mycobacterium marinum	Fig. 2 from Clay et al., 2008
defense response to bacterium decreased occurrence, abnormal	WIK + MO1-tnfrsf1a + MO2-tnfrsf1a	bacterial treatment: Mycobacterium marinum	Fig. 1 , Fig. 3 , Fig. 6 , Fig. 7 from Clay et al., 2008
posterior intestine goblet cell decreased amount, abnormal	WT + MO1-tnfrsf1a + MO2-tnfrsf1a	control	Fig. 3 from Troll et al., 2018
macrophage decreased amount, abnormal	WT + MO1-tnfrsf1a + MO2-tnfrsf1a	bacterial treatment: Mycobacterium marinum	Fig. 4 from Clay et al., 2008
gut neutrophil amount, ameliorated	sox10^t3/t3 + MO1-tnfrsf1a + MO2-tnfrsf1a	standard conditions	Fig. 1 from Rolig et al., 2017
gut cell population proliferation occurrence, ameliorated	sox10^t3/t3 + MO1-tnfrsf1a + MO2-tnfrsf1a	standard conditions	Fig. 1 from Rolig et al., 2017
ventral wall of dorsal aorta myb expression decreased distribution, abnormal	WT + MO2-tnfrsf1a + MO2-tnfrsf1b	standard conditions	Fig. 1 from Espín-Palazón et al., 2014
ventral wall of dorsal aorta hematopoietic stem cell decreased amount, abnormal	WT + MO2-tnfrsf1a + MO2-tnfrsf1b	standard conditions	Fig. 1 from Espín-Palazón et al., 2014

Citations